Medicinal cannabis in Germany - Business Report

11 Confidential __________________________________________________________________________________ II List of tables Table 1: Indications and evidence................................................................................................................... 22 Table 2: Non-approved indications and evidence .......................................................................................... 26 Table 3: National and regional regulatory instruments ................................................................................. 45 Table 4: Monitoring, distribution of patients by indication ........................................................................... 49 Table 5: Product classes in the Cannabis market ........................................................................................... 74 Table 6: Import regulations for Cannabis products from abroad .................................................................. 85 Table 7: Overview of available data sources on the Cannabis market .......................................................... 87 Table 8: Structure of the estimates used to calculate the Cannabis market in Germany ............................. 93 Table 9: Prescriptions of finished medicinal products in the Cannabis market 2018 to 2019 ....................101 Table 10: Times and periods in the AMNOG procedure for Epidyolex®. .....................................................102 Table 11: Purchase of Cannabis flowers according to THC content.............................................................112 Table 12: Pharmacy purchases of Cannabis flowers by THC content 2018 to 2019....................................112 Table 13: Bedrocan Cannabis flowers by THC and CBD content..................................................................113 Table 14: Development of recipes by special PZNs from 2018 to 2019.......................................................116 Table 15: Comparison of recipes and sales indexed across the CT districts ................................................127 Table 16: Political parties and their attitude towards the use of Cannabis.................................................168 Table 17: Cannabis products and DDD costs ................................................................................................171